Study (first author and year) | Functional Test | Follow-Up | Outcomes | Main Results | Risk of Bias | Level of Evidence (GRADE) |
---|---|---|---|---|---|---|
Brenyo et al. [45], 2012. | 6MWT | 4 years | Incident HF and Mortality ≤ 350 m VS > 350 m | HR = 1.73 95%CI [1.29–2.33]*** | Low | Not Reported |
Incident HF and Mortality Per 100-m decreased | HR = 1.25 95%CI [1.09–1.44]*** | |||||
All-Cause Mortality ≤ 350 m VS > 350 m | HR = 2.40 95%CI [1.42–4.08]*** | Moderate | ||||
All-Cause Mortality Per 100-m decreased | HR = 1.32 95%CI [1.05–1.66]** | |||||
Ferreira et al. [46], 2019. | 6MWT | 21 months (9–26 months) | Hospitalisation and Mortality 241-360 m VS > 360 m | HR = 1.44 95%CI [1.14–1.80]** | Moderate | Low |
Hospitalisation and Mortality ≤ 240 m VS > 360 m | HR = 1.73 95%CI [1.38–2.18]*** | |||||
Hospitalisation and Mortality Per each 50 m decreased | HR = 1.08 95%CI [1.04–1.11]*** | |||||
All-Cause Mortality 241-360 m VS > 360 m | HR = 1.49 95%CI [1.08–2.06]** | Moderate | ||||
All-Cause Mortality ≤ 240 m VS > 360 m | HR = 2.41 95%CI [1.76–3.29]*** | |||||
All-Cause Mortality Per each 50 m decreased | HR = 1.14 95%CI [1.09–1.18]*** | |||||
Wegrzynowska-Teodorczyk et al. [47], 2013. | 6MWT | 1 year | HF Mortality ≤ 468 m VS > 468 m | HR = 3.22 95%CI [1.17–8.86]** | Low | Moderate |
Hospitalisation and Mortality ≤ 468 m VS > 468 m | HR = 2.77 95%CI [1.30–5.88]** | Low | ||||
3 years | HF Mortality ≤ 468 m VS > 468 m | HR = 2.18 95%CI [1.18–4.03]** | Moderate | |||
Hospitalisation and Mortality ≤ 468 m VS > 468 m | HR = 1.71 95%CI [1.08–2.72]** | Low | ||||
Bittner et al. [48], 1993. | 6MWT | 1 year (242 ± 82 days) | All-Cause Mortality Per each 120 m decreased | OR = 1.50 95%CI [1.11–2.03]** | Low | Moderate |
HF Hospitalisation Per each 120 m decreased | OR = 2.60 95%CI [1.78–3.80]*** | Low | ||||
Hospitalisation and Mortality Per each 120 m decreased | OR = 1.77 95%CI [1.38–2.26]*** | Low | ||||
All-Cause Mortality < 300 m VS ≥ 450 m | OR = 3.7 95%CI [1.44–9.55]** | Moderate | ||||
All-Cause Mortality 300-375 m VS ≥ 450 m | OR = 2.78 95%CI [1.09–7.11]** | |||||
All-Cause Mortality 375-450 m VS ≥ 450 m | OR = 1.42 95%CI [0.50–4.06]* | |||||
All-Cause Hospitalisation < 300 m VS ≥ 450 m | OR = 14.02 95%CI [4.90–40.14]*** | Low | ||||
All-Cause Hospitalisation 300-375 m VS ≥ 450 m | OR = 6.21 95%CI [2.14–18.08]*** | |||||
All-Cause Hospitalisation 375-450 m VS ≥ 450 m | OR = 1.90 95%CI [0.56–6.42]* | |||||
Arslan et al. [49], 2007. | 6MWT | 2 years (18 ± 6 months) | HF Mortality ≤ 300 m VS > 300 m | HR = 2.38 95%CI [2.02–5.76]** | Moderate | Moderate |
Lee et al. [50], 2006. | 6MWT | 36 ± 12 months | Hospitalisation and Mortality 75-230 m VS > 370 m. | OR = 3.5 95%CI [1.1–11.7]** | Low | Low |
Hospitalisation and Mortality 231-310 m VS > 370 m | OR = 3.4 95%CI [1.01–11.5]** | |||||
Hospitalisation and Mortality 311-370 m VS > 370 m | OR = 4.9 95%CI [1.5–16.0]** | |||||
Curtis et al. [51], 2004. | 6MWT | 32 months | All-Cause Mortality ≤ 200 m VS > 400 m | HR = 1.59 95%CI [0.88–2.86]* | Low | Moderate |
All-Cause Mortality 201-300 m VS > 400 m | HR = 1.01 95%CI [0.57–1.79]* | |||||
All-Cause Mortality 301-400 m VS > 400 m | HR = 1.16 95%CI [0.72–1.88]* | |||||
HF Mortality ≤ 200 m VS > 400 m | HR = 2.62 95%CI [1.02–6.74]** | Moderate | ||||
HF Mortality 201-300 m VS > 400 m | HR = 0.93 95%CI [0.34–2.55]* | |||||
HF Mortality 301-400 m VS > 400 m | HR = 0.86 95%CI [0.35–2.09]* | |||||
All-Cause Hospitalisation ≤ 200 m VS > 400 m | HR = 1.76 95%CI [1.19–2.60]** | Low | ||||
All-Cause Hospitalisation 201-300 m VS > 400 m | HR = 1.41 95%CI [1.01–1.99]** | |||||
All-Cause Hospitalisation 301-400 m VS > 400 m | HR = 1.09 95%CI [0.80–1.47]* | |||||
HF Hospitalisation ≤ 200 m VS > 400 m | HR = 1.84 95%CI [0.97–3.49]* | Low | ||||
HF Hospitalisation 201-300 m VS > 400 m | HR = 1.84 95%CI [1.04–3.29]** | |||||
HF Hospitalisation 301-400 m VS > 400 m | HR = 1.45 95%CI [0.85–2.45]* | |||||
Ingle et al. [52], 2014. | 6MWT | 5 years | All-Cause Mortality Per each 10 m increased. | HR = 0.980 95%CI [0.974–0.985]*** | Low | Moderate |
Alahdab et al. [53], 2009. | 6MWT | 40 months-Mortality | All-Cause Mortality ≤ 200 m VS > 200 m | HR = 2.14 95%CI [1.20–3.81]** | Low | Moderate |
40 months-Mortality | All-Cause Mortality Per each 1 m increased | HR = 0.998 95%CI [0.995–0.999]** | ||||
18 months-Hospitali- zation | HF Hospitalisation ≤ 200 m VS > 200 m | HR = 1.62 95%CI [1.10–2.39]** | Low | |||
Mangla et al. [54], 2013. | 6MWT | 1080 days | Hospitalisation and Mortality ≤ 189 m VS > 189 m in HFpEF. | OR = 2.81 95%CI [1.24–6.40]** | Low | Low |
Hospitalisation and Mortality ≤ 189 m VS > 189 m in HFrEF. | OR = 1.94 95%CI [1.30–2.90]** | |||||
Hasin et al. [55], 2012. | 6MWT | Median 592 days (115–1453 days) | All-Cause Mortality Per 10 m walked short of 300 m | HR = 1.211 95% CI [1.108–1.322]*** | Moderate | Moderate |
Passantino et al. [56], 2006. | 6MWT | 23.9 months | All-Cause Mortality < 300 m VS ≥ 300 m | HR = 2.66 95%CI [1.60–4.42]*** | Low | Moderate |
All-Cause Mortality Per each 70 m decreased | HR = 2.03 95%CI [1.29–3.18]** | |||||
Howie-Esquivel et al. [57], 2008. | 6MWT | 90 days | HF Hospitalisation > 200 m | HR = 0.99 95%CI [0.99–1.00]* | High | Low |
Zotter-Tufaro et al. [58], 2015. | 6MWT | 14.0 ± 10.0 months | Hospitalisation and Mortality > 300 m VS ≤ 300 m | HR = 0.992 95%CI [0.990–0.995]*** | Moderate | Low |
Boxer et al. [59], 2010. | 6MWT | 4 years | All-Cause Mortality Per each 30 m increased | HR = 0.84 95%CI [0.74–0.94]** | Moderate | Moderate |
Ingle et al. [60], 2014. | 6MWT | 8 years | All-Cause Mortality Per each 10 m increased | HR = 0.988 95%CI [0.981–0.995]*** | Low | Moderate |
Guazzi et al. [61], 2009. | 6MWT | 20.4 ± 16.6 months. | Cardiac Mortality Per each 1 m increased | HR = 0.998 95%CI [0.995–1.001]* | Low | Moderate |
McCabe et al. [62], 2017. | 6MWT | 30 days | HF Hospitalisation Per each 30 m increased | OR = 0.84 95% CI [0.71–0.99]** | Moderate | Low |
Vegh et al. [63], 2014. | 6MWT | 3 years | HF Hospitalisation ≥ 350 m VS < 280 m | HR = 0.61 95% CI [0.44–0.85]** | Moderate | Low |
Hospitalisation and Mortality ≥ 350 m VS < 280 m | HR = 0.58 95% CI [0.43–0.80]*** | Low | ||||
HF Hospitalisation ≥ 402 m VS < 256 m | HR = 0.60 95% CI [0.44–0.82]*** | Low | ||||
Hospitalisation and Mortality ≥ 402 m VS < 256 m | HR = 0.55 95% CI [0.43–0.75]*** | Low | ||||
Roul et al. [64], 1998. | 6MWT | 1000 days | Hospitalisation and Mortality ≤ 300 m VS > 300 m | Log rank = 6.16 ** | Moderate | Low |
Frankenstein et al. [65], 2008. | 6MWT | 52.9 ± 36.2 months | All-Cause Mortality Per each 1 m increased | HR = 0.996 95% CI [0.995–0.997]*** | Low | Moderate |
Mene-Afejuku et al. [66], 2017. | 6MWT | 6 months | Hospitalisation and Mortality 314.66 m ± 48.17 m VS 260.59 m ± 66.65 m | OR = 0.819 95% CI [0.206–3.257]* | Moderate | Low |
Ingle et al. [67], 2007. | 6MWT | 36.6 months (28.2–45.0 months) | All-Cause Mortality Per each 1 m increased | HR = 0.998 95% CI [0.996–1.000]* | Low | Moderate |
Rostagno et al. [68], 2003. | 6MWT | 34 months | All-Cause Mortality Per each 1 m increased | HR = 0.995 95% CI [0.993–0.997]*** | Low | Moderate |
Cahalin et al. [69], 1996. | 6MWT | 62 ± 45 weeks (1–183 weeks) | Hospitalisation and Mortality < 300 m VS ≥ 300 m | X2 = 40% vs 12% ** | Moderate | Low |
Frankenstein et al. [70], 2008. | 6MWT | 42 months (22–80 months) | All-Cause Mortality Per each 1 m increased | HR = 0.996 95% CI [0.995–0.997]** | Moderate | Moderate |
Rubim et al. [71], 2006. | 6MWT | 18 months (12–24 months) | All-Cause Mortality ≥ 520 m VS < 520 m | OR = −0.0081 95% CI [0.0029–0.0133]*** | Low | Moderate |
Kanagala et al. [72], 2019. | 6MWT | 1429 days (1157–1657 days) | Hospitalisation and Mortality Per each 1 m increased | HR = 0.659 95% CI [0.465–0.934]** | Low | Low |
Zugck et al. [73], 2001. | 6MWT | 28.3 ± 14.1 months | All-Cause Mortality Per each 1 m increased | HR = 0.99 95% CI [0.98–0.99]** | Moderate | Moderate |
Cahalin et al. [74], 2013. | 6MWT | 22.8 ± 22.1 months | Cardiac Mortality Per each 1 m increased | HR = 0.99 95% CI [0.99–0.99]** | Low | Moderate |
Cardiac Mortality > 300 m VS ≤ 300 m | HR = 0.18 95% CI [0.04–0.89]** | |||||
Reibis et al. [75], 2010. | 6MWT | 731 ± 215 days | All-Cause Mortality Per each 50 m increasd | HR = 0.93 95% CI [0.86–1.00]** | Low | Moderate |
Castel et al. [76], 2009. | 6MWT | 24.4 ± 18.1 months | Cardiac Mortality < 225 m VS > 400 m | HR = 5.60 95% CI [1.23–25.30]** | Low | Moderate |
Cardiac Mortality 225-310 m VS > 400 m | HR = 1.28 95% CI [0.23–7.08]* | |||||
Cardiac Mortality 310-400 m VS > 400 m | HR = 4.10 95% CI [0.79–21.52]* | |||||
Kamiya et al. [77], 2017. | 6MWT | 2.3 ± 1.9 years | All-Cause Mortality Per each 10 m increased | HR = 0.96 95% CI [0.94–0.97]*** | Low | Moderate |
García et al. [78], 2019. | SPPB | 1 year | HF Hospitalisation SPPB ≤ 7 VS SPPB > 7 | OR = 6.7 95%CI [1.5–30.4]** | Moderate | Not Reported |
All-Cause Mortality SPPB ≤ 7 VS SPPB > 7 | OR = 1.2 95%CI [0.3–5.4]* | Very Low | ||||
Hospitalisation and Mortality SPPB ≤ 7 VS SPPB > 7 | OR = 3.6 95%CI [1.0–12.9]** | Very Low | ||||
Hornsby et al. [79], 2019. | SPPB | 6 months | Hospitalisation and Mortality Per 1-unit change in SPPB | OR = 0.81 95%CI [0.69–0.94]** | Moderate | Very Low |
Number of All-Cause Hospitalisations Per 1-unit change in SPPB | IRR = 0.92 95%CI [0.86–0.97]** | Not Reported | ||||
Days Hospitalized or Dead Per 1-unit change in SPPB | IRR = 0.85 95%CI [0.73–0.99]** | Not Reported | ||||
Chiarantini et al. [80], 2010. | SPPB | 30 months (median 444 days) | All-Cause Mortality SPPB 0 VS SPPB 9–12 | HR = 6.06 95%CI [2.19–16.76]*** | Moderate | Very Low |
All-Cause Mortality SPPB 1–4 VS SPPB 9–12 | HR = 4.78 95%CI [1.63–14.02]** | |||||
All-Cause Mortality SPPB 5–8 VS SPPB 9–12 | HR = 1.95 95%CI [0.67–5.70]* | |||||
Zaharias et al. [81], 2014. | SPPB | 3 months | Hospitalisation and Mortality Per each 1 point decreased | HR = 1.042 95%CI [0.89–1.23]* | Moderate | Very Low |
Lo et al. [82], 2015. | Gait Speed | 10 years | All-Cause Mortality < 0.8 m/s VS ≥ 0.8 m/s | HR = 1.37 95%CI [1.10–1.70]** | Low | Low |
Pulignano et al. [83], 2016. | Gait Speed | 1 year | All-Cause Mortality Gait speed (tertiles) | HR = 0.620 95%CI [0.434–0.884]** | Low | Low |
HF Hospitalisation Gait speed (tertiles) | OR = 0.697 95%CI [0.547–0.899]** | Low | ||||
All-Cause Hospitalisation Gait speed (tertiles) | HR = 0.741 95%CI [0.613–0.895]** | Low | ||||
Chaudhry et al. [84], 2013. | Gait Speed | 20 years | All-Cause Hospitalisation ≤ 0.8 m/s VS > 0.8 m/s | HR = 1.28 95%CI [1.06–1.55]** | Low | Low |
Hospitalisation and Mortality ≤ 0.8 m/s VS > 0.8 m/s | HR = 1.31 95%CI [1.08–1.58]** | Low | ||||
Tanaka et al. [85], 2018. | Gait Speed | 1.7 ± 0.5 years | All-Cause Mortality 1.0–1.14 m/s VS > 1.14 m/s | HR = 0.80 95%CI [0.37–1.74]* | Moderate | Low |
All-Cause Mortality 0.82–0.99 m/s VS > 1.14 m/s | HR = 1.46 95%CI [0.75–2.83]* | |||||
All-Cause Mortality < 0.82 m/s VS > 1.14 m/s | HR = 2.65 95%CI [1.35–5.20]** | |||||
Tanaka et al. [86], 2019. | Gait Speed | 2.1 ± 1.9 years | All-Cause Mortality Per each 0.1 m/s increased | HR = 0.83 95% CI [0.73–0.95]** | Low | Low |
HF Hospitalisation Per each 0.1 m/s increased | HR = 0.91 95% CI [0.83–0.99]** | Low | ||||
Hospitalisation and Mortality Per each 0.1 m/s increased | HR = 0.90 95% CI [0.83–0.97]** | Low | ||||
Rodríguez-Pascual et al. [87], 2017. | Gait Speed | 1 year | All-Cause Mortality GS < 0.65 m/s VS GS ≥ 0.65 m/s | HR = 1.86 95% CI [0.95–3.65]* | Low | Low |
All-Cause Hospitalisation GS < 0.65 m/s VS GS ≥ 0.65 m/s | HR = 1.57 95% CI [0.98–2.52]* | Low | ||||
Vidán et al. [88], 2016. | Gait Speed | 1 year | All-Cause Mortality GS < 0.65 m/s VS GS ≥ 0.65 m/s | HR = 1.48 95% CI [0.95–2.32]* | Low | Low |
All-Cause Hospitalisation GS < 0.65 m/s VS GS ≥ 0.65 m/s | OR = 1.67 95% CI [0.98–2.85]* | Low | ||||
Kamiya et al. [77], 2017. | Gait Speed | 2.3 ± 1.9 years | All-Cause Mortality Per each 0.1 m/s increased | HR = 0.87 95% CI [0.81–0.93]*** | Low | Low |